Fibroblast growth factor 20 is protective towards dopaminergic neurons in vivo in a paracrine manner

por Boshoff, Eugene.L., Fletcher, Edward.J.R., Duty, Susan
Publicado 2018

Chondroitinase ABC reduces dopaminergic nigral cell death and striatal terminal loss in a 6-hydroxydopamine partial lesion mouse model of Parkinson’s disease

por Fletcher, Edward J. R., Moon, Lawrence D. F., Duty, Susan
Publicado 2019

Drug repurposing strategies of relevance for Parkinson’s disease

por Fletcher, Edward J. R., Kaminski, Thomas, Williams, Gareth, Duty, Susan
Publicado 2021

Animal models of Parkinson’s disease: a guide to selecting the optimal model for your research

por Lama, Joana, Buhidma, Yazead, Fletcher, Edward J.R., Duty, Susan
Publicado 2021

Targeted repositioning identifies drugs that increase fibroblast growth factor 20 production and protect against 6-hydroxydopamine-induced nigral cell loss in rats

por Fletcher, Edward J. R., Jamieson, Aran D., Williams, Gareth, Doherty, Patrick, Duty, Susan
Publicado 2019

Neuroanatomical and Microglial Alterations in the Striatum of Levodopa-Treated, Dyskinetic Hemi-Parkinsonian Rats

por Fletcher, Edward J. R., Finlay, Clare J., Amor Lopez, Ana, Crum, William R., Vernon, Anthony C., Duty, Susan
Publicado 2020

A Single Domain Shark Antibody Targeting the Transferrin Receptor 1 Delivers a TrkB Agonist Antibody to the Brain and Provides Full Neuroprotection in a Mouse Model of Parkinson’s...

por Clarke, Emily, Stocki, Pawel, Sinclair, Elizabeth H., Gauhar, Aziz, Fletcher, Edward J. R., Krawczun-Rygmaczewska, Alicja, Duty, Susan, Walsh, Frank S., Doherty, Patrick, Rutkowski, Julia Lynn
Publicado 2022